Ypsomed
YPSN.SWPre-clinicalYpsomed offers pharmaceutical companies innovative injection systems such as pens and autoinjectors for subcutaneous self-medication.
Market Cap
$2.3B
Founded
2003
Focus
Medical DevicesDrug Delivery
YPSN.SW · Stock Price
USD 137.5855.43 (-28.72%)
Historical price data
About
Ypsomed offers pharmaceutical companies innovative injection systems such as pens and autoinjectors for subcutaneous self-medication.
Funding History
1IPOUndisclosedUndisclosedJun 15, 2004
Publications
20
Patents
20
Company Info
TypePublic
Founded2003
LocationBurgdorf, Switzerland
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
3Brain
Pre-clinical · Zug
Baxiva
Pre-clinical · Zug
AC Bioscience
Pre-clinical · Lausanne
Abrinca Genomics
Pre-clinical · Zurich
AdipoGen
Pre-clinical · Liestal
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile